-+ 0.00%
-+ 0.00%
-+ 0.00%

Rapport Therapeutics Director Ramiro Sanchez Reports Acquisition of $98,477.64 in Common Shares

PUBT·10/23/2026 20:03:06
Rapport Therapeutics Director Ramiro Sanchez Reports Acquisition of $98,477.64 in Common Shares
  • Rapport Therapeutics director Ramiro Sanchez purchased 3,600 shares of Common Stock at $27.3549 per share.
  • His direct holdings totaled 3,600 shares following the purchase.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rapport Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-430397), on October 23, 2026, and is solely responsible for the information contained therein.